Across TCGA pan-cancer cohorts, GNB5 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GNB5’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where GNB5 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types GNB5 is over-expressed in tumor, although a few such as LUAD and CCRCC show the opposite, repressed pattern.
LUAD, CCRCC, and HNSC are the cancer types where GNB5 tumor–normal differential expression is most reproducible.